Vimarsana
Biggest News Aggregation in the World

Peter Guinto News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peter Guinto. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peter Guinto Today - Breaking & Trending Today

In a seminal development for Wisconsin's economy, manufacturing has begun returning home - Vimarsana News

In a seminal development for Wisconsin's economy, manufacturing has begun returning home

Manufacturers say one of their biggest worries is that a shortage of skilled workers threatens to undermine growth.

Source: yahoo.com
Will the Taiwan earthquake disrupt the global chip shortage? - Vimarsana News

Will the Taiwan earthquake disrupt the global chip shortage?

While the human cost remains the primary focus, with rescue efforts ongoing, the impact on Taiwan's role as a chipmaking powerhouse is under close scrutiny from industries worldwide A powerful...

Resilinc and Public Spend Forum Collaborate to Bring - Vimarsana News

Resilinc and Public Spend Forum Collaborate to Bring

Partnership Provides Deep Insights into Government Suppliers and Global Supply Chains...

Chip manufacturers press for federal funding as bill flails in Congress - Vimarsana News

Chip manufacturers press for federal funding as bill flails in Congress

Construction industry news, trends and jobs for building professionals who want mobile-friendly content.

Johnson & Johnson (NYSE:JNJ), Merck & Company, Inc. (NYSE:MRK) - Medically Necessary: Stimulus Bill Has Billions For Vaccine Distribution, Executive Orders Signal Supply Chain Focus And Merck Helps J&J Produce Vaccine - Vimarsana News

Johnson & Johnson (NYSE:JNJ), Merck & Company, Inc. (NYSE:MRK) - Medically Necessary: Stimulus Bill Has Billions For Vaccine Distribution, Executive Orders Signal Supply Chain Focus And Merck Helps J&J Produce Vaccine

$5.2 billion for research and development related to vaccines or therapeutics. Some of that money could also go to manufacturing and production, but the bill doesn't specify how much.  The bill's text focuses on COVID-19 but would also allow the agency to use the funds for other diseases. The Food and Drug Administration would receive $500 million. Part of that money would go toward facilitating COVID-19 vaccine manufacturing, inspecting manufacturers producing vaccines or therapeutics, and oversight of the supply chain.  Part of the supply chain oversight would include mitigating drug sho...